Exposure to cyclooxygenase-2 inhibitors and risk of cancer: Nested case-control studies

British Journal of Cancer

Volumn 105, Issue 3, 2011, Pages 452-459

  Vinogradova, Y ^a   Coupland, C ^a   Hippisley Cox, J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; MELOXICAM; ROFECOXIB;

ADULT; AGED; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EXPOSURE; DRUG UTILIZATION; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOMA; PRIORITY JOURNAL; REVIEW; RISK REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2 INHIBITORS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS;

EID: 79960842091     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.252     Document Type: Review

References (44)

1. Arber N, Eagle CJ, Spicak J, Rácz I, Dite P, Hajer J (2006) Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 355: 885-895 (Pubitemid 44315981)
2. Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundström C, Klareskog L (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54(3): 692-701
3. Bardia A, Ebbert J, Vierkant R, Limburg P, Anderson K, Wang A, Olson J, Vachon C, Cerhan J (2007) Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality. J Natl Cancer Inst 99(11): 881-889 (Pubitemid 47073510)
4. Barnes NLP, Warnberg F, Farnie G, White D, Jiang W, Anderson E, Bundred NJ (2007) Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. Br J Cancer 96(4): 575-582
5. Bernatsky S, Lee JL, Rahme E (2007) Non-Hodgkin's lymphoma-meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories. Rheumatology 46(4): 690-694 (Pubitemid 46523318)
6. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, Hess TM, Woloj GM, Boisserie F, Anderson WF, Viner JL, Bagheri D, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Gordon GB, Hawk ET (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355(9): 873-884 (Pubitemid 44315980)
7. British Medical Association, Royal Pharmaceutical Society (2010) British National Formulary, vol. 59. British Medical Journal Publishing Group and Pharmaceutical Press: London
8. Chan FKL, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL (2010) Celecoxib versus omeprazole and diclofenac in patients with osteoar-thritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet 376(9736): 173-179
9. Chang E, Cronin-Fenton D, Friis S, Hjalgrim H, Sørensen H, Pedersen L (2010) Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in northern Denmark. Cancer Epidemiol Biomarkers Prev 19(1): 59-64
10. D'Arca D, LeNoir J, Wildemore B, Gottardo F, Bragantini E, Shupp-Byrne D, Zanesi N, Fassan M, Croce CM, Gomella LG, Baffa R (2010) Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor. Urol Oncol 28(2): 189-194
11. Department of Health (2007) NHS Repeat Dispensing Schemes In England. Department of Health: London
12. Flick ED, Chan KA, Bracci PM, Holly EA (2006) Use of nonsteroidal antiinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study. Am J Epidemiol 164(5): 497-504 (Pubitemid 44576617)
13. Gallicchio L, Visvanathan K, Burke A, Hoffman SC, Helzlsouer KJ (2007) Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD. Int J Cancer 121: 211-215 (Pubitemid 46753870)
14. Garcia Rodriguez LA, Huerto-Alvarez C (2001) Reduced risk of colorectal cancer among long-term users of asprin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 12(1): 88-93 (Pubitemid 32006467)
15. Gill JK, Maskarinec G, Wilkens LR, Pike MC, Henderson BE, Kolonel LN (2007) Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Am J Epidemiol 166(10): 1150-1158 (Pubitemid 350022753)
16. Harris RE, Beebe-Donk J, Alshafie GA (2006) Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (cox-2) inhibitors. BMC Cancer 6: 27
17. Harris RE, Beebe-Donk J, Alshafie GA (2007) Reduced risk of human lung cancer by selective cyclooxygenase 2 (cox-2) blockade: results of a case control study. Int J Biol Sci 3: 328-334 (Pubitemid 46953958)
18. Hernández-Díaz S, García Rodríguez L (2006) Nonsteroidal anti-inflammatory drugs and risk of lung cancer. Int J Cancer 120: 1565-1572
19. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ (2010) Validation and validity of diagnoses in the general practice research database: a systematic review. Br J Clin Pharmacol 69(1): 4-14
20. Hippisley-Cox J, Pringle M, Cater R, Wynn A, Hammersley V, Coupland C, Hapgood R, Horsfield P, Teasdale S (2003) The electronic record in primary care-regression or progression? Cross-sectional survey. BMJ 326: 1439-1443 (Pubitemid 36776156)
21. Hippisley-Cox J, Vinogradova Y, Coupland C, Pringle M (2005) Comparison of key practice characteristics between general practices in England and Wales and general practices in the QResearch data. Report to the Health and Social Care Information Centre. University of Nottingham. Report no. R 21
22. Jacobs E, Rodriguez C, Mondul A, Connell C, Henley S, Calle E, Thun M (2005) A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. J Natl Cancer Inst 97: 975-980 (Pubitemid 41430563)
23. Khan MNA, Lee YS (2009) Cyclooxygenase inhibitors: scope of their use and development in cancer chemotherapy. Med Res Rev 31(2): 161-201
24. Kim S, Martin C, Galanko J, Woosley JT, Schroeder JC, Keku TO, Satia JA, Halabi S, Sandler RS (2008) Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African Americans. Am J Epidemiol 168(11): 1292-1300
25. Kirsh VA, Kreiger N, Cotterchio M, Sloan M, Theis B (2007) Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. Am J Epidemiol 166(6): 709-716 (Pubitemid 47347905)
26. Koki A, Masferrer J (2002) Celecoxib: a specific COX-2 inhibitor with anticancer properties. Cancer Control 9(2 Suppl): 28-35 (Pubitemid 34457338)
27. Liu X, Yue P, Zhou Z, Khuri F, Sun S (2004) Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 96(23): 1769-1780 (Pubitemid 39654571)
28. Manish I, Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ (2005) Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Clin Cancer Res 11: 1999-2007 (Pubitemid 40471866)
29. Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97(11): 805-812 (Pubitemid 40909123)
30. MHRA (2005) Updated Advice On the Safety of Selective Cox-2 Inhibitors. Medicines and Healthcare products Regulatory Agency: London
31. Nakamura S, Kobayashi M, Shibata K, Sahara N, Shigeno K, Shinjo K, Naito K, Hayashi H, Ohnishi K (2006) Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells. Leuk Res 30(2): 123-135 (Pubitemid 41773333)
32. Nakanishi Y, Kamijo R, Takizawa K, Hatori M, Nagumo M (2001) Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines. Eur J Cancer 37(12): 1570-1578 (Pubitemid 32744690)
33. National Statistics (2000) Key Health Statistics from General Practice 1998: Series MB6 (no 2). Office for National Statistics: London
34. Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M (2005) Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer. BMC Cancer 5(1): 159
35. Ready A, Velicer C, McTiernan A, White E (2008) NSAID use and breast cancer risk in the VITAL cohort. Breast Cancer Res Treat 109(3): 533-543 (Pubitemid 351692052)
36. Royston P (2005) Multiple imputation of missing values: update of ice. Stata J 5(4): 527-536 (Pubitemid 43708457)
37. Smith N, Wilson A, Weekes T (1995) Use of Read codes in development of a standard data set. BMJ 311: 313-315
38. Solomon SD, McMurray JJV, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352(11): 1071-1080 (Pubitemid 40365348)
39. Sørensen HT, Friis S, Nørgaird B, Mellemkjær L, Blot WJ, McLaughlin JK, Ekbom A, Baron JA (2003) Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 88: 1687-1692 (Pubitemid 36760410)
40. Statistical Bulletin (2010) Cancer Statistics Registration: Registrations of Cancer Diagnosed in 2007, England: Series MB1 (no 38). Office for National Statistics: London
41. The NHS Information Centre for health and social care(2008) Prescription Cost Analysis, England 200. Prescribing Support Unit: London
42. Thomas E, Brewster DH, Black RJ, Macfarlane GJ (2000) Risk of malignancy among patients with rheumatic conditions. Int J Cancer 88(3): 497-502
43. Tran-Thanh D, Buttars S, Wen Y, Wilson C, Done S (2010) Cyclooxygenase-2 inhibition for the prophylaxis and treatment of preinvasive breast cancer in a her-2/neu mouse model. Cancer Prev Res 3(2): 202-211
44. Westlake S, Office for National Statistics (2008) Report: cancer incidence and mortality in the United Kingdom and constituent countries, 2003-2005. HSQ 40